Javascript must be enabled to continue!
Gynecomastia and Leydigioma: An Unexpected Case Report Outcome
View through CrossRef
We report a case of a 19-year-old male referred to the Endocrine Unit because of gynecomastia. Initial investigation revealed elevated levels of estradiol (E2) along with secondary hypogonadism (hypotestosteronemia and severe oligoasthenoteratozoospermia (OAT)) despite normal testicular volume (12 mL) and secondary sexual characteristics. Surprisingly, an ultrasound examination revealed a small hypoechoic mass (1.1 cm) with intense intralesional vascularization within the right testicle, even though tumor markers were normal. Surgical removal of testicular mass led to the identification of Leydigioma, and the patient showed regression of gynecomastia during the nine-month follow-up. Unexpectedly, hypergonadotropinemia manifested along with normal testosterone (T) levels and significant improvement in OAT. Magnetic resonance imaging (MRI) showed pituitary hyperplasia (PH). Gynecomastia represents an atypical manifestation of Leydig cell tumors and typically resolves after surgical removal. However, unilateral orchiectomy may determine compensatory PH. Currently, it is uncertain whether the shift from hypogonadotropic to permanent hypergonadotropinemia was the only factor responsible for the high sperm count occurring in our patient. Further research is needed to elucidate the underlying mechanisms.
Title: Gynecomastia and Leydigioma: An Unexpected Case Report Outcome
Description:
We report a case of a 19-year-old male referred to the Endocrine Unit because of gynecomastia.
Initial investigation revealed elevated levels of estradiol (E2) along with secondary hypogonadism (hypotestosteronemia and severe oligoasthenoteratozoospermia (OAT)) despite normal testicular volume (12 mL) and secondary sexual characteristics.
Surprisingly, an ultrasound examination revealed a small hypoechoic mass (1.
1 cm) with intense intralesional vascularization within the right testicle, even though tumor markers were normal.
Surgical removal of testicular mass led to the identification of Leydigioma, and the patient showed regression of gynecomastia during the nine-month follow-up.
Unexpectedly, hypergonadotropinemia manifested along with normal testosterone (T) levels and significant improvement in OAT.
Magnetic resonance imaging (MRI) showed pituitary hyperplasia (PH).
Gynecomastia represents an atypical manifestation of Leydig cell tumors and typically resolves after surgical removal.
However, unilateral orchiectomy may determine compensatory PH.
Currently, it is uncertain whether the shift from hypogonadotropic to permanent hypergonadotropinemia was the only factor responsible for the high sperm count occurring in our patient.
Further research is needed to elucidate the underlying mechanisms.
Related Results
Hydatid Disease of The Brain Parenchyma: A Systematic Review
Hydatid Disease of The Brain Parenchyma: A Systematic Review
Abstarct
Introduction
Isolated brain hydatid disease (BHD) is an extremely rare form of echinococcosis. A prompt and timely diagnosis is a crucial step in disease management. This ...
Breast Carcinoma within Fibroadenoma: A Systematic Review
Breast Carcinoma within Fibroadenoma: A Systematic Review
Abstract
Introduction
Fibroadenoma is the most common benign breast lesion; however, it carries a potential risk of malignant transformation. This systematic review provides an ove...
Chest Wall Hydatid Cysts: A Systematic Review
Chest Wall Hydatid Cysts: A Systematic Review
Abstract
Introduction
Given the rarity of chest wall hydatid disease, information on this condition is primarily drawn from case reports. Hence, this study systematically reviews t...
Comparison of Tamoxifen with Danazol in the Management of Idiopathic Gynecomastia
Comparison of Tamoxifen with Danazol in the Management of Idiopathic Gynecomastia
Idiopathic gynecomastia, unilateral or bilateral, is a common physical finding in normal men. Successful treatment using tamoxifen (antiestrogen) and danazol (antiandrogen) has rec...
Spironolactone-digoxin synergizes gynecomastia: A case report
Spironolactone-digoxin synergizes gynecomastia: A case report
Gynecomastia refers to a proliferation of breast tissue in the males that causes imbalances in estrogen and androgen levels, resulting in increased or unopposed estrogen action on ...
Overview on Epidemiology, Causes and Management of Gynecomastia
Overview on Epidemiology, Causes and Management of Gynecomastia
Background: Gynecomastia is characterized by the benign enlargement of male breast tissue, a condition witnessed across varied age brackets and influenced by several factors. While...
Hydatid Cyst of The Orbit: A Systematic Review with Meta-Data
Hydatid Cyst of The Orbit: A Systematic Review with Meta-Data
Abstarct
Introduction
Orbital hydatid cysts (HCs) constitute less than 1% of all cases of hydatidosis, yet their occurrence is often linked to severe visual complications. This stu...
Content and Readability Analysis of Patient-Reported Outcome Measures for Gynecomastia
Content and Readability Analysis of Patient-Reported Outcome Measures for Gynecomastia
Abstract
Gynecomastia, characterized by the benign enlargement of male breast tissue, has a lifetime prevalence of 65% and can significantly impact quality of lif...

